{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-107164","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2023-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.038919+00:00","generated_at":"2026-06-10T03:53:33.085447+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ReShape Lifesciences prices $3.0M public offering at $0.33/unit; warrants amended","bullets":["Offering of 9.1M units at $0.33/unit; each unit: 1 share (or pre-funded warrant) + 1.5 warrants exercisable at $0.33.","Net proceeds ~$2.8M; expected use: Lap-Band marketing, ReShapeCare development, working capital.","Existing warrants for ~1.35M shares amended to $0.33 exercise price upon closing.","Closing expected Oct 3, 2023; Maxim Group sole placement agent with 7% fee plus placement agent warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-107164","json":"https://secwatch.observer/filing/0001104659-23-107164.json","markdown":"https://secwatch.observer/filing/0001104659-23-107164.md","text":"https://secwatch.observer/filing/0001104659-23-107164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923107164/0001104659-23-107164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923107164/tm2327726d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:53:33.085447+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b36aa05cee72808ba37fcdcc6b4d8af2d3037cca","claim":"Vyome Holdings, Inc entered into Securities Purchase Agreement with certain investors valued at approximately $2.8 million (effective 2023-09-29).","evidence_excerpt":"On September 29, 2023, ReShape Lifesciences Inc. (the \"Company\") entered into a Securities Purchase Agreement (the \"Purchase Agreement\") with certain investors (the \"Investors\")","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923107164/0001104659-23-107164-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors"},{"label":"Value","value":"approximately $2.8 million"},{"label":"Effective","value":"2023-09-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}